Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V V Maleev

Showing results (161-170 of 184) with videos related to

Pageof 19
Sort By:
Terapevticheskii Arkhiv|December 30, 2023
[Features of the course of COVID-19 in patients with type 2 diabetes mellitus]E A Karaseva, V A Martynov, T E Filatova, et al.
Klinicheskaia Meditsina|December 1, 1990
[Clinical characteristics of the outbreak of Salmonella infection caused by Salmonella enteritidis]N D Iushchuk, L E Brodov, K I Chekalina, et al.
Terapevticheskii Arkhiv|April 1, 2015
[Clinical efficacy of arbidol (umifenovir) in the therapy of influenza in adults: preliminary results of the multicenter double-blind randomized placebo-controlled study ARBITR]O I Kiselev, V V Maleev, E G Deeva, et al.
Terapevticheskii Arkhiv|February 27, 2015
[Adenovirus pneumonia with a fatal outcome in adults]S B Yatsyshina, V V Samchuk, V V Vasilyev, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii|March 31, 2011
[Molecular characterization of pandemic influenza viruses A/H1N1(sw2009) isolated in Russia in 2009-2010]S B Iatsyshina, A N Minenko, P V Voloshina, et al.
Terapevticheskii Arkhiv|May 17, 2019
Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR)N Yu Pshenichnaya, V A Bulgakova, N I Lvov, et al.
Biulleten' Eksperimental'Noi Biologii I Meditsiny|August 1, 1995
[The effect of chitosan on biological properties of gram-negative bacterial endotoxins]A M Poliakova, A V Kravchenko, I M Ermak, et al.
Terapevticheskii Arkhiv|December 21, 2012
[Clinical presentation of "new" tick-borne borreliosis caused by Borrelia miyamotoi]D S Sarksyan, A E Platonov, L S Karan, et al.
Terapevticheskii Arkhiv|March 3, 2017
[Pharmacoepidemiological study of the course of influenza and other acute respiratory viral infections in risk groups]V A Bulgakova, A A Poromov, A I Grekova, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii|January 30, 2019
[GENETIC CHARACTERISTICS OF INFLUENZA A/H3N2 AND B VIRUSES THAT HAD CIRCULATED IN RUSSIA IN 2013 - 2015]S B Yatsyshina, A N Renteeva, A V Valdokhina, et al.
Pageof 19

Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
Terapevticheskii Arkhiv|December 30, 2023
[Features of the course of COVID-19 in patients with type 2 diabetes mellitus]E A Karaseva, V A Martynov, T E Filatova, et al.
Klinicheskaia Meditsina|December 1, 1990
[Clinical characteristics of the outbreak of Salmonella infection caused by Salmonella enteritidis]N D Iushchuk, L E Brodov, K I Chekalina, et al.
Terapevticheskii Arkhiv|April 1, 2015
[Clinical efficacy of arbidol (umifenovir) in the therapy of influenza in adults: preliminary results of the multicenter double-blind randomized placebo-controlled study ARBITR]O I Kiselev, V V Maleev, E G Deeva, et al.
Terapevticheskii Arkhiv|February 27, 2015
[Adenovirus pneumonia with a fatal outcome in adults]S B Yatsyshina, V V Samchuk, V V Vasilyev, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii|March 31, 2011
[Molecular characterization of pandemic influenza viruses A/H1N1(sw2009) isolated in Russia in 2009-2010]S B Iatsyshina, A N Minenko, P V Voloshina, et al.
Terapevticheskii Arkhiv|May 17, 2019
Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR)N Yu Pshenichnaya, V A Bulgakova, N I Lvov, et al.
Biulleten' Eksperimental'Noi Biologii I Meditsiny|August 1, 1995
[The effect of chitosan on biological properties of gram-negative bacterial endotoxins]A M Poliakova, A V Kravchenko, I M Ermak, et al.
Terapevticheskii Arkhiv|December 21, 2012
[Clinical presentation of "new" tick-borne borreliosis caused by Borrelia miyamotoi]D S Sarksyan, A E Platonov, L S Karan, et al.
Terapevticheskii Arkhiv|March 3, 2017
[Pharmacoepidemiological study of the course of influenza and other acute respiratory viral infections in risk groups]V A Bulgakova, A A Poromov, A I Grekova, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii|January 30, 2019
[GENETIC CHARACTERISTICS OF INFLUENZA A/H3N2 AND B VIRUSES THAT HAD CIRCULATED IN RUSSIA IN 2013 - 2015]S B Yatsyshina, A N Renteeva, A V Valdokhina, et al.
Pageof 19